A detailed history of Fortis Group Advisors, LLC transactions in Embecta Corp. stock. As of the latest transaction made, Fortis Group Advisors, LLC holds 1 shares of EMBC stock, worth $13. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Previous 1 -0.0%
Holding current value
$13
Previous $13,000 7.69%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$12.35 - $19.33 $12 - $19
-1 Reduced 50.0%
1 $13,000
Q4 2023

Mar 04, 2024

BUY
$12.87 - $19.09 $12 - $19
1 Added 100.0%
2 $38,000
Q3 2023

Dec 01, 2023

BUY
$15.0 - $22.17 $15 - $22
1 New
1 $15,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $799M
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Fortis Group Advisors, LLC Portfolio

Follow Fortis Group Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortis Group Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortis Group Advisors, LLC with notifications on news.